| Document |
Document Title |
|
WO/2019/226571A1 |
A liquid drug delivery formulation forms a foam when combined with a gas source. The formulation includes water, at least one hydrophilic solvent, at least one surfactant or foaming agent, and a drug particle which is a mixture of a ther...
|
|
WO/2019/223753A1 |
Disclosed are a controlled-release dosage form with an absorption window in the upper gastrointestinal tract and a preparation method therefor, wherein the controlled-release dosage form comprises a controlled-release platform and a rete...
|
|
WO/2019/222570A1 |
Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surfac...
|
|
WO/2019/222273A1 |
Method and system for controlling oxygen delivery to a cell implant. In one embodiment, the system includes a water electrolyzer, a cell capsule, a gas conduit, a total fluid pressure sensor, and a controller. The water electrolyzer gene...
|
|
WO/2019/222572A1 |
Articles for rapid release of components including, for example, quick release capsules, are generally provided. Advantageously, in some embodiments, the articles described herein may be configured to prevent fluid from contacting a comp...
|
|
WO/2019/222704A1 |
Electrolytic gas generator and multi-functional current collector for use in same. In one embodiment, the current collector is constructed both to conduct current from an electrode to a conductive lead and to conduct gas generated at the...
|
|
WO/2019/216960A1 |
A probe may be inserted into a body cavity to perform diagnostic intervention(s), therapeutic intervention(s), or both. The probe may be inserted through a body aperture that is naturally occurring or man-made, intentionally or by accide...
|
|
WO/2019/214020A1 |
A portable nebulizer capable of automatically adjusting the nebulization rate according to pulmonary ventilation volume, comprising a housing (1), a medicine liquid box (2), a nozzle (3), a battery (4) provided in the housing (1), a circ...
|
|
WO/2019/216535A1 |
The present invention relates to a liquid drug injection device for injecting a liquid drug into a nasal cavity and paranasal sinuses through a nostril and, more specifically, to a device for injecting a liquid drug into a nasal cavity a...
|
|
WO/2019/213344A1 |
A gastrostomy or nasogastric tube venting unit has a containment vessel for measuring fluids expelled with gastric gas before, during, after, or independent from feeding. The venting unit is particularly well-suited for pediatric or extr...
|
|
WO/2019/213648A1 |
The invention locally delivers a chemotherapeutic or a radiographic contrast agent to an upper tract urothelial carcinoma (UTUC). The invention includes a balloon catheter with a working channel and a balloon placed into the ureter/renal...
|
|
WO/2019/210134A1 |
A variety of different intravaginal drug delivery devices are described for the delivery of estrogens and progestins. The release rate of estrogens and progestins can be controlled by varying the matrix material or by the application of ...
|
|
WO/2019/205326A1 |
Provided is a circulation pipeline (10) for intracavity hyperthermic perfusion, the circulation pipeline comprising a heating tank (100), a liquid intake pipeline (101), a liquid discharge pipeline (102), a circulating pump (200), a pre-...
|
|
WO/2019/201095A1 |
Disclosed is an implantable tube device for the middle digestive tract, comprising a bendable elastic hollow tube with a proximal end and a distal end, and at least one fixed line that is fixed in the hollow tube at a distance of 15-30 c...
|
|
WO/2019/199913A1 |
Embodiments disclosed herein include devices for time release of measured quantities of an active ingredient and storage of animal management information. One embodiment disclosed herein releases an active ingredient, and then, at option...
|
|
WO/2019/199749A1 |
A power injector system having a power injector for enabling delivery of fluid in an injection procedure to be performed on a patient may include one or more processors; a first user interface; and a second user interface. The first user...
|
|
WO/2019/193747A1 |
This overtube is equipped with: a first wall section that juxtaposes at least two lumens including a first lumen into which an endoscope is inserted and a second lumen into which a medical apparatus is inserted, the first wall section be...
|
|
WO/2019/193591A1 |
A catheter for ultrasonic-driven bladder therapeutic agent delivery, including: a tube having a proximal expandable portion and a distal end, and at least one transducer sleeve accommodating at least one ultrasound transducer mounted on ...
|
|
WO/2019/185398A1 |
The present invention makes available an active substance applicator (10, 110) for an implant (30), in particular a joint implant. The active substance applicator has a main body (11), an active substance chamber (12) formed in the main ...
|
|
WO/2019/178607A1 |
The present disclosure provides an apparatus (200) for delivering an anesthetic agent (222) to a target tissue in a nasal cavity (100) of a patient. The apparatus (200) includes an elongated shaft (212) with a proximal end (214) and a di...
|
|
WO/2019/178485A1 |
This document relates to devices and methods for delivering a fluid to the surfaces of the oropharynx and/or to the palatine tonsils.
|
|
WO/2019/178513A1 |
A transzonular intravitreal injector includes a hollow tube housing having an open proximal tube end, an open distal tube end, and a body extending between the proximal tube end and the distal tube end. The body defines a cannula having ...
|
|
WO/2019/175864A1 |
The present invention relates to delivery devices adapted to mechanically dilate a pelvic anatomical canal, the delivery devices comprise a composition formulated as a gel comprising a beneficial or therapeutic agent, said delivery devic...
|
|
WO/2019/175055A1 |
An urethral antimicrobial delivery device (1) comprising; a deformable reservoir (101) in fluid connection with an elongate member (102), the elongate member comprising a lumen, the elongate member having a proximal end and a distal end,...
|
|
WO/2019/178071A1 |
Ingestible devices with a relatively large payload volume or sample volume, as well as related components, systems and methods, are disclosed.
|
|
WO/2019/178367A1 |
Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods are provided. In one embodiment, a substance dispensing apparatus includes a housing sized and shaped for hand...
|
|
WO/2019/171308A1 |
A casing holding one or more brachytherapy seeds for implanting in a patient, which in turn carry atoms of a radioactive element for radiotherapy treatment is filled with a viscous liquid in a manner preventing radiation from the one or ...
|
|
WO/2019/169299A1 |
In various embodiments, a drug pump includes a housing and, within the housing, an expandable drug reservoir at least part of which is exposed to a pressurized propellant. The propellant exerts a substantially constant pressure on the dr...
|
|
WO/2019/168985A1 |
A composition comprising a small molecule therapeutic agent and an organic acid compound is described. The small molecule therapeutic agent (i) has a water solubility at room temperature of less than about 1.0 g/L and (ii) is a base. The...
|
|
WO/2019/159062A1 |
A delivery system for delivering a drug depot to a site within a patient, the system comprising: a cannula; a delivery stylet configured and dimensioned to be receivable by and slidable forwardly and backwardly within the cannula includi...
|
|
WO/2019/161042A1 |
The present disclosure describes a delivery device. The delivery device of the present disclosure can include one or more pullout resistors that can anchor the delivery device to the patient' s abdomen. The pullout resistors can reduce f...
|
|
WO/2019/158791A1 |
The present invention relates to an implantable device for the selective removal of molecules from tissues or fluids so as to allow the selective removal of a particular molecule of interest (target molecule) from any type of fluid solut...
|
|
WO/2019/147875A1 |
A method of reducing the feeling of vaginal dryness is provided. The method includes a female user suffering from vaginal dryness administering a vaginal care composition to her vaginal area, preferably the vaginal introitus and/or exter...
|
|
WO/2019/147613A1 |
The present invention provides systems and methods for downstream delivery of agents. The invention includes membranes that are attachable to the inner wall of a blood vessel and deposits one or more agents into a subject's bloodstream. ...
|
|
WO/2019/147876A1 |
A method of reducing the feeling of vaginal dryness is provided. The method includes a female user suffering from vaginal dryness administering a vaginal care composition to her vaginal introitus and, optionally, external vaginal tissues...
|
|
WO/2019/147824A1 |
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a PDE4 inhibitor.
|
|
WO/2019/147320A1 |
A catheter that is configured to achieve high velocity injections of contrast solution that will not readily wash out in retrograde blood flow. The distal end of the catheter can include a plurality of fluid outlet openings. The fluid ou...
|
|
WO/2019/147877A1 |
A method of reducing the feeling of vaginal dryness is provided. The method includes a female user providing an amount of a vaginal care composition on at least a portion of the outer surface of an applicator and administering at least a...
|
|
WO/2019/147937A1 |
A kit for treating vaginal dryness is provided. The kit comprises a hand held applicator and a dispenser or receptacle storing a vaginal care composition.
|
|
WO/2019/135213A1 |
An in-vivo insertable device, which is insertable into an at least partially hollow organ of a human or animal, including a housing formed of a material and being of a contour which enable it to be inserted into an at least partially hol...
|
|
WO/2019/136133A1 |
The disclosed subject matter relates to a cleavable microneedle for delivery of therapeutic agent, wherein the needle includes a longitudinal body having a detachable portion that comprises at least one therapeutic agent. The microneedle...
|
|
WO/2019/133931A1 |
The present disclosure relates to a gastrointestinal delivery device of a chitosan dressing, where the delivery device is capable of stop bleeding, in particular in connection with TURP procedures. The delivery device may be used in all ...
|
|
WO/2019/121686A1 |
The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active...
|
|
WO/2019/116229A1 |
Disclosed devices for intranasal administration of medicament to a patient can comprise a hand-held unit comprising a gripping portion for being held by an operator, a spray head having a spray apparatus and a nozzle, a control unit coup...
|
|
WO/2019/118871A1 |
A handheld therapeutic apparatus and method of treatment are disclosed. In one example, the apparatus includes a valve system, a detachable gas cartridge housing unit that houses a gas cartridge or gas delivery from an outside gas cylind...
|
|
WO/2019/111132A1 |
The present disclosure is in the field of gastroretentive dosage forms. A gastroretentive dosage form for extended retention in a stomach is provided.
|
|
WO/2019/071135A9 |
The present invention provides an implantable bioreactor comprising cells enclosed within an enclosure, said cells being capable of producing paracrine factors, wherein the enclosure is collapsible or expandable or both or neither, where...
|
|
WO/2019/109144A1 |
A device (10,210) for treatment of a canal associated with an orifice includes a flexible stem portion (20, 220) adapted for insertion along the canal and having an expandable member (24, 224) carried by the stem portion (20, 220) at or ...
|
|
WO/2019/105519A1 |
Described herein is a medicated uterine balloon; a Tranexamic Acid (TXA) Coated or Eluted Uterine Balloon (TACUB) for use in primary management of postpartum haemorrhage (PPH). It enforces the tamponade effect of currently used plain non...
|
|
WO/2019/091159A1 |
An integrated rhinitis recovery and care device having a magnetization function comprises a bottle body, a medicine liquid nozzle (1), a medicine liquid duct (2), a recycle duct (3), a pump-out mechanism (4), and a nasal cavity bionic pl...
|
